These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...

By Brendan Pierson and Dietrich Knauth (Reuters) -A Washington jury on Tuesday ordered Bayer to pay $100 million to four ...

Bayer Cropscience Ltd. key Products/Revenue Segments include Insecticides, Pesticides, Herbicides, Weedicides & Fungicides, Other Operating Revenue, Scrap and Royalty Income for the year ending 31-Mar ...

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

The OTC pain medication market is set to achieve significant valuation growth by 2034, up from 2024 levels. The market is ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...